FMS vs. DVA, SHC, AGL, PGNY, CO, VMD, OTRK, MGRX, BRTX, and MRAI
Should you be buying Fresenius Medical Care stock or one of its competitors? The main competitors of Fresenius Medical Care include DaVita (DVA), Sotera Health (SHC), agilon health (AGL), Progyny (PGNY), Global Cord Blood (CO), Viemed Healthcare (VMD), Ontrak (OTRK), Mangoceuticals (MGRX), BioRestorative Therapies (BRTX), and Marpai (MRAI). These companies are all part of the "miscellaneous health & allied services, not elsewhere classified" industry.
Fresenius Medical Care (NYSE:FMS) and DaVita (NYSE:DVA) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, community ranking, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment.
DaVita has a net margin of 6.61% compared to Fresenius Medical Care's net margin of 2.48%. DaVita's return on equity of 68.52% beat Fresenius Medical Care's return on equity.
Fresenius Medical Care currently has a consensus price target of $24.00, indicating a potential upside of 12.81%. DaVita has a consensus price target of $144.67, indicating a potential downside of 1.67%. Given Fresenius Medical Care's higher probable upside, equities analysts plainly believe Fresenius Medical Care is more favorable than DaVita.
8.3% of Fresenius Medical Care shares are held by institutional investors. Comparatively, 90.1% of DaVita shares are held by institutional investors. 2.0% of DaVita shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
DaVita has lower revenue, but higher earnings than Fresenius Medical Care. DaVita is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.
In the previous week, Fresenius Medical Care had 7 more articles in the media than DaVita. MarketBeat recorded 13 mentions for Fresenius Medical Care and 6 mentions for DaVita. DaVita's average media sentiment score of 1.32 beat Fresenius Medical Care's score of 0.50 indicating that DaVita is being referred to more favorably in the news media.
DaVita received 88 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 61.75% of users gave DaVita an outperform vote while only 53.99% of users gave Fresenius Medical Care an outperform vote.
Fresenius Medical Care has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500. Comparatively, DaVita has a beta of 1.04, meaning that its stock price is 4% more volatile than the S&P 500.
Summary
DaVita beats Fresenius Medical Care on 13 of the 18 factors compared between the two stocks.
Get Fresenius Medical Care News Delivered to You Automatically
Sign up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Fresenius Medical Care Competitors List
Related Companies and Tools
